©The Author(s) 2025.
World J Gastroenterol. Oct 7, 2025; 31(37): 111914
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.111914
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.111914
Table 3 Laboratory parameters measured before treatment in different alpha-fetoprotein level groups, mean ± SD
| Parameter | Low AFP group | Medium AFP group | High AFP group | P value1 |
| Blood ammonia (μmol/L) | 188.5 ± 50.1 | 185.2 ± 48.3 | 190.3 ± 52.7 | 0.8216 |
| Albumin (g/L) | 25.8 ± 3.9 | 26.1 ± 3.7 | 25.6 ± 4.0 | 0.9308 |
| Total bilirubin (μmol/L) | 145.3 ± 35.2 | 142.6 ± 33.8 | 148.1 ± 36.5 | 0.8627 |
| ALT (U/L) | 265.4 ± 70.8 | 260.2 ± 68.1 | 268.7 ± 72.3 | 0.8795 |
| AST (U/L) | 225.6 ± 60.3 | 220.3 ± 58.4 | 229.1 ± 61.9 | 0.8998 |
| γ-GT (U/L) | 485.2 ± 120.6 | 478.3 ± 118.1 | 492.7 ± 123.8 | 0.9339 |
| PTA (%) | 28.3 ± 5.1 | 29.1 ± 5.4 | 27.8 ± 4.9 | 0.9657 |
- Citation: Guo WB, Wang LY, Guo XJ, Yang J, Li W, Shen FY, Li YT, Yang JH, Tai WL. Prognostic value of serum alpha-fetoprotein kinetics in liver failure on artificial liver support. World J Gastroenterol 2025; 31(37): 111914
- URL: https://www.wjgnet.com/1007-9327/full/v31/i37/111914.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i37.111914